417-422
Original Paper
Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model
Satoru Murata, Hiroyuki Tajima, Yutaka Abe, Shiro Onozawa and Fumio Uchiyama, et al.
423-429
Original Paper
HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy
Catalina Falo, Abelardo Moreno, Mar Varela, Belen Lloveras and Agnès Figueras, et al.
431-435
Original Paper
Midkine as a prognostic marker for gastrointestinal stromal tumors
Jussuf T. Kaifi, Henning C. Fiegel, Svanheidur L. Rafnsdottir, Kuniaki Aridome and Paulus G. Schurr, et al.
437-444
Original Paper
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group
P. Terheyden, A.-K. Kortüm, H.-J. Schulze, B. Durani and R. Remling, et al.
445-453
Original Paper
Continuing with letrozole offers greater benefits
Fritz Jänicke
455-470
Original Paper
Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic–pathologic–clinical correlations
Hege Vangstein Aamot, Emina Emilia Torlakovic, Marianne Brodtkorb Eide, Harald Holte and Sverre Heim
471-476
Original Paper
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients
Manabu Yamamoto, Hideo Baba, Yasushi Toh, Takeshi Okamura and Yoshihiko Maehara
477-485
Original Paper
Diminished quality of life in patients with cancer correlates with tryptophan degradation
Katharina Schroecksnadel, Michael Fiegl, Karin Prassl, Christiana Winkler and Hubert A. Denz, et al.
487-492
Original Paper
Transforming growth factor-β downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma
Cheryn Song, Sun-Young Jun, Jun-Hyuk Hong and Hanjong Ahn
493-500
Original Paper
Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells
E. Kassi, Z. Papoutsi, H. Pratsinis, N. Aligiannis and M. Manoussakis, et al.